LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Geldanamycin | 10.0 | uM | LJP5 | 2 | O01 | 72 | hr | 868 | 529 | 3486 | 0.1517 | -0.1295 |
MDA-MB-231 | Geldanamycin | 10.0 | uM | LJP5 | 3 | O01 | 72 | hr | 868 | 643 | 3486 | 0.1844 | -0.0860 |
MDA-MB-231 | Geldanamycin | 10.0 | uM | LJP6 | 1 | O01 | 72 | hr | 868 | 582 | 3486 | 0.1669 | -0.1093 |
MDA-MB-231 | Geldanamycin | 10.0 | uM | LJP6 | 2 | O01 | 72 | hr | 868 | 532 | 3486 | 0.1526 | -0.1284 |
MDA-MB-231 | Geldanamycin | 10.0 | uM | LJP6 | 3 | O01 | 72 | hr | 868 | 551 | 3486 | 0.1580 | -0.1211 |
MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP5 | 1 | E01 | 72 | hr | 868 | 509 | 3486 | 0.1460 | -0.1372 |
MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP5 | 2 | E01 | 72 | hr | 868 | 558 | 3486 | 0.1601 | -0.1184 |
MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP5 | 3 | E01 | 72 | hr | 868 | 692 | 3486 | 0.1985 | -0.0673 |
MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP6 | 1 | C01 | 72 | hr | 868 | 582 | 3486 | 0.1669 | -0.1093 |
MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP6 | 2 | C01 | 72 | hr | 868 | 609 | 3486 | 0.1747 | -0.0990 |
MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP6 | 3 | C01 | 72 | hr | 868 | 790 | 3486 | 0.2266 | -0.0298 |
MDA-MB-231 | GSK1904529A | 10.0 | uM | LJP6 | 1 | H19 | 72 | hr | 868 | 3416 | 3486 | 0.9798 | 0.9731 |
MDA-MB-231 | GSK1904529A | 10.0 | uM | LJP6 | 2 | H19 | 72 | hr | 868 | 3355 | 3486 | 0.9623 | 0.9498 |
MDA-MB-231 | GSK1904529A | 10.0 | uM | LJP6 | 3 | H19 | 72 | hr | 868 | 3356 | 3486 | 0.9626 | 0.9502 |
MDA-MB-231 | Omipalisib | 10.0 | uM | LJP6 | 1 | N01 | 72 | hr | 868 | 993 | 3486 | 0.2848 | 0.0477 |
MDA-MB-231 | Omipalisib | 10.0 | uM | LJP6 | 2 | N01 | 72 | hr | 868 | 1225 | 3486 | 0.3514 | 0.1363 |
MDA-MB-231 | Omipalisib | 10.0 | uM | LJP6 | 3 | N01 | 72 | hr | 868 | 875 | 3486 | 0.2510 | 0.0026 |
MDA-MB-231 | GSK 690693 | 10.0 | uM | LJP5 | 1 | F19 | 72 | hr | 868 | 3110 | 3486 | 0.8920 | 0.8562 |
MDA-MB-231 | GSK 690693 | 10.0 | uM | LJP5 | 2 | F19 | 72 | hr | 868 | 3134 | 3486 | 0.8989 | 0.8654 |
MDA-MB-231 | GSK 690693 | 10.0 | uM | LJP5 | 3 | F19 | 72 | hr | 868 | 3177 | 3486 | 0.9113 | 0.8818 |
MDA-MB-231 | GW843682X | 10.0 | uM | LJP6 | 1 | B13 | 72 | hr | 868 | 1227 | 3486 | 0.3519 | 0.1371 |
MDA-MB-231 | GW843682X | 10.0 | uM | LJP6 | 2 | B13 | 72 | hr | 868 | 1092 | 3486 | 0.3132 | 0.0855 |
MDA-MB-231 | GW843682X | 10.0 | uM | LJP6 | 3 | B13 | 72 | hr | 868 | 1335 | 3486 | 0.3829 | 0.1783 |
MDA-MB-231 | HG-5-113-01 | 10.0 | uM | LJP5 | 1 | B07 | 72 | hr | 868 | 907 | 3486 | 0.2602 | 0.0149 |
MDA-MB-231 | HG-5-113-01 | 10.0 | uM | LJP5 | 2 | B07 | 72 | hr | 868 | 952 | 3486 | 0.2731 | 0.0320 |